Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus.
about
Focal Targeting of the Bacterial Envelope by Antimicrobial PeptidesMechanisms of drug resistance: daptomycin resistanceQuantitative proteomic view associated with resistance to clinically important antibiotics in Gram-positive bacteria: a systematic reviewCyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteriaFunctional linkage between genes that regulate osmotic stress responses and multidrug resistance transporters: challenges and opportunities for antibiotic discoveryStaphylococcal phenotypes induced by naturally occurring and synthetic membrane-interactive polyphenolic β-lactam resistance modifiersWhole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureusEmergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.LysPGS formation in Listeria monocytogenes has broad roles in maintaining membrane integrity beyond antimicrobial peptide resistance.Staphylococcus aureus requires cardiolipin for survival under conditions of high salinity.Genetic basis for daptomycin resistance in enterococci.Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin ActivityDaptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect")Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanismsWhole-genome analyses of Enterococcus faecium isolates with diverse daptomycin MICs.Lysyl-phosphatidylglycerol attenuates membrane perturbation rather than surface association of the cationic antimicrobial peptide 6W-RP-1 in a model membrane system: implications for daptomycin resistance.Role of mprF1 and mprF2 in the pathogenicity of Enterococcus faecalis.Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid contentCarotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides.Site-specific mutation of the sensor kinase GraS in Staphylococcus aureus alters the adaptive response to distinct cationic antimicrobial peptides.Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.Additional routes to Staphylococcus aureus daptomycin resistance as revealed by comparative genome sequencing, transcriptional profiling, and phenotypic studies.Site-specific mutation of Staphylococcus aureus VraS reveals a crucial role for the VraR-VraS sensor in the emergence of glycopeptide resistance.Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates.Comparative genome sequencing of an isogenic pair of USA800 clinical methicillin-resistant Staphylococcus aureus isolates obtained before and after daptomycin treatment failure.Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approachCorrelation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation.In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides.Staphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotype.Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial PeptidesMultidrug Intrinsic Resistance Factors in Staphylococcus aureus Identified by Profiling Fitness within High-Diversity Transposon Libraries.Differential Adaptations of Methicillin-Resistant Staphylococcus aureus to Serial In Vitro Passage in Daptomycin: Evolution of Daptomycin Resistance and Role of Membrane Carotenoid Content and Fluidity.Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus.Telavancin in therapy of experimental aortic valve endocarditis in rabbits due to daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus.Targeting bacterial membrane function: an underexploited mechanism for treating persistent infectionsβ-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin.
P2860
Q26744785-DFDC108C-C136-4E54-AF40-789FB4A190FBQ26779944-49A4EB20-2BDA-45F2-8FAC-9526CB713CE5Q26796165-5B4B90D2-6DBC-4E7F-8EDD-B753BAA15CCAQ26863225-C50B66ED-EBAE-4428-96DD-F9518E0C2D18Q27023447-6445DD8D-30F4-49FB-ADD3-DA90EF44D2A4Q28541941-30572CA5-6BBF-4C1A-BD4F-B66B0BD01F4EQ28740293-93C9898B-C9C8-48E7-BCC1-003E0ADCEFCFQ31131146-024F359E-D04E-461B-95B3-7082E66BBD9BQ33779111-26436F37-DA81-4E9D-9DF7-42D3802E7694Q33795292-66CD7B3D-874D-4A6B-A465-AB9ECCD1C830Q33876255-F84C9ABF-3DBD-4D3A-9ADE-D164502E2D75Q33939055-E984DB54-3E94-408B-B7B5-A212EAA293F9Q34045273-71F6D585-7A79-47E6-AC87-1027496DC248Q34045376-77AC21C9-46D9-4D04-B940-1DF4835174A5Q34058150-18B3521E-AFA8-4E62-BEB0-53537912A444Q34151075-119A7511-E3A3-46FA-903F-6523566D6C22Q34313862-95FB9D39-20BB-4180-8F2D-C218EA8ECB96Q34405922-AEF56642-93CD-4047-90B6-296A57416002Q34529075-5AD28F40-4331-4499-AF14-90E04EDD1C1AQ34595733-7E238760-192A-4DF9-B3E8-39197FAD7CF4Q34597770-BB910FD5-14E5-4151-AEE7-65DB37864330Q34648042-5984D71A-0639-4C45-92BD-3CAFE3F11958Q34737155-DF7743F6-1CA0-4B9D-B216-AC189A0BA9B6Q34779009-9A74900D-6D45-4E9E-A1AF-6A42F7A50A88Q34932588-1186AB63-BAB3-4686-959F-DF1A9FF94C89Q35096905-3F2AAC09-DCE6-4BFA-BA08-3B02598A156BQ35139449-ED4FFD47-0F2D-49C5-A854-1E1FB2B06AA2Q35191555-9B7BE0BF-F3AA-42E9-B986-E144E3576FC3Q35256159-325F7B1E-4EE7-453B-BC71-8A8217B8BC5AQ35619094-1E41BF23-A2D5-4209-B7B1-610EB1783A66Q35665343-94A6BCBF-F008-42EF-98D3-34A3D58128E9Q35746096-2D830801-0E95-4560-BF47-0E7202198391Q35860154-3AE0B9A9-28F1-4A3A-A272-3DFFE73B2CA6Q36105516-C3FE03E6-E543-4EBA-BFDA-B2709A0F60FCQ36200018-036BD343-782C-4767-AC59-6DA2995E5751Q36217683-D78B577C-6A21-4C9F-B44F-EFB3077A49F6Q36364106-F296FF2E-7EED-4039-BCB6-7FEA70A70648Q36393640-007FF010-9C57-42BE-A2B0-C3232D2132ADQ36396117-A42997E8-8452-4901-B985-2CC1C44C4411Q36401160-7E464767-8603-4B76-B893-82EA4F49AB4C
P2860
Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Analysis of cell membrane char ...... sistant Staphylococcus aureus.
@en
Analysis of cell membrane char ...... sistant Staphylococcus aureus.
@nl
type
label
Analysis of cell membrane char ...... sistant Staphylococcus aureus.
@en
Analysis of cell membrane char ...... sistant Staphylococcus aureus.
@nl
prefLabel
Analysis of cell membrane char ...... sistant Staphylococcus aureus.
@en
Analysis of cell membrane char ...... sistant Staphylococcus aureus.
@nl
P2093
P2860
P356
P1476
Analysis of cell membrane char ...... sistant Staphylococcus aureus.
@en
P2093
Aileen Rubio
Arnold S Bayer
Ayumi Sawa
Cynthia C Nast
Michael R Yeaman
Nagendra N Mishra
Soo-Jin Yang
P2860
P304
P356
10.1128/AAC.01682-08
P407
P577
2009-03-30T00:00:00Z